Replies to post #2428 on PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Kronberg]

King in my opinion there are the final trials.One year for Europe and 2 years for FDA and the company has the opportunity to significantly shorten the time for FDA'approval.If Balance study confirms the superiority of PRX-102 over Fabrazyme we are big winners.